Results 311 to 315 of about 16,343,665 (315)

Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway

Cardiovascular Drugs and Therapy, 2018
K. Chen, Mubarak Rekep, Wei Wei, Qian Wu, Qin Xue, Sujuan Li, Jiahui Tian, Quan Yi, Gen-Shui Zhang, Gui-ping Zhang, Qing Xiao, Jiandong Luo, Yinghua Liu   +12 more
semanticscholar   +1 more source

A unique type of GSK-3 inhibitor brings new opportunities to the clinic

Science Signaling, 2016
Avital Licht-Murava, R. Paz, Lilach Vaks, L. Avrahami, Batya Plotkin, M. Eisenstein, H. Eldar-Finkelman   +6 more
semanticscholar   +1 more source

GSK-3 Inhibitors: A Double-Edged Sword? – An Update on Tideglusib

Drug Research, 2018
Theodore lemuel Mathuram, L. Reece, K. Cherian   +2 more
semanticscholar   +1 more source

Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor.

Journal of Molecular Graphics and Modelling, 2016
C. M. Nisha, Ashwini Kumar, A. Vimal, B. M. Bai, D. Pal, Awanish Kumar   +5 more
semanticscholar   +1 more source

A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy

Movement Disorders, 2014
E. Tolosa, I. Litvan, Günter U. Höglinger, D. Burn, A. Lees, M. Andrés, Belén Gómez-Carrillo, T. León, T. Ser   +8 more
semanticscholar   +1 more source